Unjha Formulations

Unjha Formulations Inventory

The Inventory of Unjha Formulations (531762.BO) as of Oct 27, 2026 is 6.31 M INR. In the previous year, Inventory was 10.33 M INR — a change of -38.92% (lower).

Inventory

6.31 MINR

YoY

-38.92%

Last updated:

Inventory of Unjha Formulations is 2026 6.31 M INR. Inventory of Unjha Formulations was 2025 10.33 M INR. It decreases by -38.92% lower compared to the previous year.

The Unjha Formulations Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2019
5.50 M INR
Jan 1, 2020
4.84 M INR
Jan 1, 2021
11.47 M INR
Jan 1, 2022
11.37 M INR
Jan 1, 2023
11.37 M INR
Jan 1, 2024
12.59 M INR
Jan 1, 2025
10.33 M INR
Jan 1, 2026
6.31 M INR
The Unjha Formulations Inventory history
YEARInventoryYoY
6.31 MINR-38.92%
10.33 MINR-17.96%
12.59 MINR+10.76%
11.37 MINR0.00%
11.37 MINR-0.94%
11.47 MINR+137.23%
4.84 MINR-12.07%
5.50 MINR-45.97%
10.18 MINR-12.52%
11.64 MINR+111.91%
5.49 MINR-24.68%
7.29 MINR+2.16%
7.14 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Unjha Formulations Stock analysis

What does Unjha Formulations do? Unjha Formulations Ltd. generates revenue through the manufacturing and export of Ayurvedic products, primarily targeting international markets. The company's key products include Fibron SF Powder, Albendazole Bolus, and Fibermate, which are isabgol-based formulations. Anchor Sat-Isabgol, available in 50g, 100g, 200g, and 400g sizes, is a flagship product, while Fibron and Fibron SF (Sugar Free) come in 100g and 300g packages. The firm focuses on export markets for its veterinary medicinal formulations not for human use, alongside its Ayurvedic powder and tablet lines. The company's revenue streams are derived from the sale of Fibron SF Powder, Albendazole Bolus, and Fibermate to international buyers seeking Ayurvedic and veterinary products. Anchor Sat-Isabgol is sold in multiple sizes, catering to consumer demand for isabgol-based health supplements. Unjha Formulations Ltd. also produces Small Volume Ayurvedic Isabgol powder, which is exported globally. The primary customers are international importers and distributors specializing in Ayurvedic and veterinary medicinal products. Export markets drive the company's business model, with Fibron SF Powder and Fibron being key revenue contributors. The firm's veterinary medicinal formulation not for human use, including Albendazole Bolus, targets agricultural and livestock sectors. Anchor Sat-Isabgol's availability in various sizes ensures broad market reach, while the company's focus on isabgol-based formulations aligns with global demand for natural health products. Unjha Formulations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Unjha Formulations stock

Inventory of Unjha Formulations is 6.31 M INR in 2026.

Inventory of Unjha Formulations changed from 10.33 M INR to 6.31 M INR, representing a -38.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Unjha Formulations since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Unjha Formulations historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Unjha Formulations

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Unjha Formulations